Modified Citrus Pectin
Natural Anti-Metastatic Support
Modified Citrus Pectin (MCP) is derived from pectin, a high molecular-weight polysaccharide present in the cell wall of all plants. Pectin can be pH degraded to produce a modified (smaller) polysaccharide - modified citrus pectin - which has anti-metastatic properties. MCP appears to bind with galactans on cancer cell surfaces, inhibiting aggregation and adherence to normal cells and offering anti-metastatic protection in animal models.
Modified citrus pectin is readily absorbed in the GI tract and is completely non-toxic to humans. Although there are no good studies to verify MCP’s effectiveness in humans, animal studies repeatedly demonstrate MCP’s anti-metastatic capabilities. Because of the lack of toxicity of modified citrus pectin, and because conventional medicine has no drug or treatment to prevent metastasis, I recommend taking either MCP or larch in cases of cancer to help prevent or delay metastasis.
Dose: 2-3 teaspoons, 3 times daily. This may be added to your Super Shake or other beverage.
1.) Guess BW, Scholz MC,Strum SB,LamRY, Johnson HJ, Jennrich RI. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study.Prostate Cancer and Prostatic Diseases (2003) 6, 301–304. doi:10.1038/sj.pcan.4500679
2.) Nangia-Makker P, Hogan V, Honjo Y, et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst. 2002;94:1854-1862.
3.) Strum S, Scholz M, McDermed J, et al. Modified citrus pectin slows PSA doubling time: A pilot clinical trial. Presentation: International Conference on Diet and Prevention of Cancer, Tampere, Finland. May 28, 1999 - June 2, 1999.
4.) Yan J, Katz AE. PectaSol-C Modified Citrus Pectin Induces Apoptosis and Inhibition of Proliferation in Human and Mouse Androgen-Dependent and Independent Prostate Cancer Cells. Integr Cancer Ther. 2010. http://www.ncbi.nlm.nih.gov/pubmed/20462856